ABcann Global Recruits Dr. Michael Shannon as Chief Medical Consultant
June 29, 2017 09:19 ET
|
ABcann Medicinals
OTTAWA, June 29, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce that it has retained the services of Dr. Michael Shannon as its...
ABcann Global Extends Research Agreement with the University of Guelph
June 26, 2017 08:00 ET
|
ABcann Medicinals
OTTAWA, June 26, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce that it has amended and extended the research contract currently...
ABcann Global and Cannabis Wheaton Sign Interim Agreement for Construction of Additional Cannabis Cultivation Facility
May 29, 2017 16:37 ET
|
ABcann Medicinals; Cannabis Wheaton Income Corp.
VANCOUVER, British Columbia, May 29, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX.V:ABCN) (formerly Panda Capital Inc.) (“ABcann”) and Cannabis Wheaton Income Corp. (TSX.V:CBW) ("Cannabis...
ABcann Extends Agreement With Medical Cannabis Pioneer
May 09, 2017 07:30 ET
|
ABcann Medicinals
OTTAWA, May 09, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (the “Company”) is pleased to announce that Raphael Mechoulam has agreed to extend his role as an advisor to the...
ABcann Global Announces Appointment of W. Brett Wilson to Advisory Board
May 04, 2017 08:30 ET
|
ABcann Medicinals
NAPANEE, Ontario, May 04, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSXV:ABCN) (the “Company”) is pleased to announce the appointment of W. Brett Wilson to the Advisory Board of the...
ABcann Global Announces Closing of Qualifying Transaction and Concurrent Financings
May 03, 2017 11:06 ET
|
ABcann Medicinals
NAPANEE, Ontario, May 03, 2017 (GLOBE NEWSWIRE) -- ABCANN GLOBAL CORPORATION (TSX-V:ABCN) (formerly Panda Capital Inc.) (“ABcann” or the “Company”) is pleased to announce that it has completed its...
Panda and ABcann Medicinals Announce Multi-Stage Product Testing Methodology
April 24, 2017 09:00 ET
|
ABcann Medicinals
OTTAWA, April 24, 2017 (GLOBE NEWSWIRE) -- Panda Capital Inc. (NEX:PDA.H) (the “Company”) is pleased to announce details of the multi-stage product testing methodology at ABcann Medicinals Inc....
Panda and ABcann Medicinals Announce Conditional Approval of Qualifying Transaction
March 30, 2017 14:02 ET
|
ABcann Medicinals; Panda Capital Inc.
OTTAWA, Ontario, March 30, 2017 (GLOBE NEWSWIRE) -- Panda Capital Inc. (NEX:PDA.H) (the “Company”) is pleased to announce that it has received conditional approval from the TSX Venture Exchange (the...